| HST |
Report |
Q2 adjusted FFO per diluted share |
BEAT |
pred ~$0.62 vs. cons $0.61 |
MEDIUM |
| HST |
Report |
Q2 comparable hotel RevPAR growth |
BEAT |
pred ~5.4% vs. cons 5.0% |
MEDIUM |
| HST |
Report |
Q2 Adjusted EBITDAre |
BEAT |
pred ~$505M vs. cons $499M |
MEDIUM |
| HST |
Guide |
Comparable hotel RevPAR growth |
BETTER |
guide ~4.3% vs. cons 4.2% (FY2026) |
MEDIUM |
| HST |
Guide |
Adjusted EBITDAre |
BETTER |
guide ~$1.845B vs. cons $1.825B (FY2026) |
MEDIUM |
| HST |
Guide |
Adjusted FFO per diluted share |
BETTER |
guide ~$2.18 vs. cons $2.16 (FY2026) |
MEDIUM |
| HST |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.8% |
— |
MEDIUM |
| HST |
Return |
5-day cumulative residual |
+0.8% (FADE) |
Q2 World Cup and luxury-demand upside should produce an initial positive reaction, but guide ~$2.18 vs. cons $2.16 implies only modest out-period revisions; the raised full-year RevPAR outlook still embeds second-half growth of roughly 2.5%-3.0% after an unusually strong first half, encouraging a partial fade. |
MEDIUM |